pyrrolidine-2,4-dicarboxylic acid has been researched along with MPTP Neurotoxicity Syndrome in 1 studies
pyrrolidine-2,4-dicarboxylic acid: a glutamate uptake inhibitor
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Matarredona, ER | 1 |
| Santiago, M | 1 |
| Machado, A | 1 |
| Cano, J | 1 |
1 other study available for pyrrolidine-2,4-dicarboxylic acid and MPTP Neurotoxicity Syndrome
| Article | Year |
|---|---|
Lack of involvement of glutamate-induced excitotoxicity in MPP+ toxicity in striatal dopaminergic terminals: possible involvement of ascorbate.
Topics: 1-Methyl-4-phenylpyridinium; Amino Acids, Essential; Animals; Ascorbic Acid; Aspartic Acid; Dicarbox | 1997 |